Drug discovery – the facts
The Tufts Center for the Study of Drug Discovery in Massachusetts provided a very full response to a request for information on the time and costs involved in developing a new drug in the US. Here's what they sent.
1 - Our 'success rates' study is available at the publisher's website, without a royalty.
http://www.nature.com/clpt/journal/v69/n5/index.html
Scan the Commentary section for DiMasi
There are two articles in the issue:
DiMasi JA: Risks in new drug development: approval success rates for investigational drugs. Clinical Pharmacology & Therapeutics 2001 May;69(5):297-307 [RS 2109]
DiMasi JA: New drug development in the United States 1963-1999. Clinical Pharmacology & Therapeutics 2001 May;69(5):286-96 [RS 2108]
The second article gives total drug development time, from discovery to approval.
2 – The following article is available at the publisher's website, and at other websites.
DiMasi JA, Hansen RW, Grabowski HG: The price of innovation: new estimates of drug development costs. Journal of Health Economics 2003 Mar;22(2):151-85 [RS 2302]
Some libraries receive the journal.
Some libraries have access to Science Direct, from Elsevier. If your institution is not a subscriber, then you will be asked for a credit card. The cost is $30.
Go to http://www.sciencedirect.com, search on DiMasi
Or use Google Scholar, http://scholar.google.com/advanced_scholar_search, search on DiMasi
3 - Drug development costs in the USA
| Cost | 2000/year $ |
2003/year $ |
2004/year $ |
2005/year $ |
2006/year $ |
| Discovery to approval | 802 million |
848 m |
868 m |
899 m |
930 m |
| Post-approval R&D* | 95 million |
100 m |
103 m |
107 m |
111 m |
* FDA mandated studies, does not include marketing


